Relacionar Columnas Neuro IIa PharmacologyVersión en línea Matching classifications with prototypes and indications. por Norria Brice, DNP, RN, ACNP-BC 1 Dopaminergic agent 2 Anticholinergic agent 3 Indirect-acting cholinergic agonist 4 Narcotic agonist-antagonist 5 Direct-acting cholinergic agonist 6 Centrally-acting skeletal muscle relaxant 7 Narcotic Agonist 8 Narcotic antagonist 9 Direct-acting skeletal muscle relaxant _____Prototype: Benztropine (Cogentin)_____Indications: Adjunctive therapy for Parkinson's disease; relief of symptoms of parkinsonism that accompany neuroleptic therapy. _____Prototype: Pentazocine (Talwin)_____Indications: relief of moderate to severe pain; preanesthetic medication & supplement to surgical anesthesia. _____Prototype: Pyridostigmine (Mestinon)_____Indications: Treatment of myesthenia gravis; antidote for nondepolarizing neuromuscular junction blockers; nerve gas antidote. _____Prototype: Morphine (Rexanol)_____Indications: Relief of moderate to severe acute or chronic pain. _____Prototype: Bethanechol (Duvoid)_____Indications: non-obstructive urinary retention (postoperative, postpartum, or neurogenic bladder) _____Prototype: Baclofen (Lioresal)_____Indications: Alleviation of s/s of spasticity, for use in spinal cord injuries or spinal cord diseases. _____Prototype: Naloxone (Narcan)_____Indications: reversal agent for opioid overdose; complete or partial reversal of narcotic depression. _____Prototype: Levadopa (generic)_____Indications: Treatment of parkinsonism and Parkinson's disease. _____Prototype: Dantrolene (Dantrium)_____Indications: Control of spasticity resulting from UMN disorders; Preoperatively to prevent/manage malignant hyperthermia
Crear